Receive our newsletter – data, insights and analysis delivered to you
July 2, 2009

Bayer Files Patent Infringement Lawsuit Against Teva

Bayer Schering and Bayer HealthCare together with Schering have filed a patent infringement lawsuit against Teva Pharmaceuticals over Teva's application for approval to market Levitra for the treatment of erectile dysfunction. The lawsuit was filed in the US Federal Court in the District

By cms admin

Bayer Schering and Bayer HealthCare together with Schering have filed a patent infringement lawsuit against Teva Pharmaceuticals over Teva’s application for approval to market Levitra for the treatment of erectile dysfunction.

The lawsuit was filed in the US Federal Court in the District of Delaware against Teva Pharmaceuticals and Teva Pharmaceutical Industries.

The patent at issue in the suit is Bayer Schering Pharma’s US Patent No 6362178 which is only set to expire in 2018. Levitra is marketed by Schering-Plough and GlaxoSmithKline in the US.

Bayer Schering is a speciality pharmaceutical company focused on diagnostic imaging, general medicine, speciality medicine and women’s healthcare.

Related Companies

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU